Display options
Share it on

Front Microbiol. 2021 Oct 05;12:747618. doi: 10.3389/fmicb.2021.747618. eCollection 2021.

Alternative Approaches for the Management of Diabetic Foot Ulcers.

Frontiers in microbiology

Cassandra Pouget, Catherine Dunyach-Remy, Alix Pantel, Adeline Boutet-Dubois, Sophie Schuldiner, Albert Sotto, Jean-Philippe Lavigne, Paul Loubet

Affiliations

  1. Virulence Bactérienne et Infections Chroniques, INSERM U1047, Université de Montpellier, Nîmes, France.
  2. Virulence Bactérienne et Infections Chroniques, INSERM U1047, Université de Montpellier, Service de Microbiologie et Hygiène Hospitalière, Clinique du Pied Gard Occitanie, CHU Nîmes, Nîmes, France.
  3. Virulence Bactérienne et Infections Chroniques, INSERM U1047, Université de Montpellier, Service des Maladies Métaboliques et Endocriniennes, Clinique du Pied Gard Occitanie, CHU Nîmes, Le Grau-du-Roi, France.
  4. Virulence Bactérienne et Infections Chroniques, INSERM U1047, Université de Montpellier, Service des Maladies Infectieuses et Tropicales, Clinique du Pied Gard Occitanie, CHU Nîmes, Nîmes, France.

PMID: 34675910 PMCID: PMC8524042 DOI: 10.3389/fmicb.2021.747618

Abstract

Diabetic foot ulcers (DFU) represent a growing public health problem. The emergence of multidrug-resistant (MDR) bacteria is a complication due to the difficulties in distinguishing between infection and colonization in DFU. Another problem lies in biofilm formation on the skin surface of DFU. Biofilm is an important pathophysiology step in DFU and may contribute to healing delays. Both MDR bacteria and biofilm producing microorganism create hostile conditions to antibiotic action that lead to chronicity of the wound, followed by infection and, in the worst scenario, lower limb amputation. In this context, alternative approaches to antibiotics for the management of DFU would be very welcome. In this review, we discuss current knowledge on biofilm in DFU and we focus on some new alternative solutions for the management of these wounds, such as antibiofilm approaches that could prevent the establishment of microbial biofilms and wound chronicity. These innovative therapeutic strategies could replace or complement the classical strategy for the management of DFU to improve the healing process.

Copyright © 2021 Pouget, Dunyach-Remy, Pantel, Boutet-Dubois, Schuldiner, Sotto, Lavigne and Loubet.

Keywords: alternative therapeutic approaches; antibiofilm; biofilm; chronic wound; diabetic foot

Conflict of interest statement

CP is the recipient of a grant from Biofilm Control (Bourse CIFRE). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could

References

  1. Plast Reconstr Surg Glob Open. 2019 Jan 15;7(1):e2047 - PubMed
  2. Antimicrob Resist Infect Control. 2019 May 16;8:76 - PubMed
  3. Curr Diabetes Rev. 2013 Jan 1;9(1):7-24 - PubMed
  4. Int J Antimicrob Agents. 2009 Apr;33(4):343-7 - PubMed
  5. Int J Oral Sci. 2015 Mar 23;7(1):1-7 - PubMed
  6. J Tissue Viability. 2006 Nov;16(4):6-10 - PubMed
  7. Int J Oral Sci. 2014 Dec;6(4):189-94 - PubMed
  8. Antimicrob Agents Chemother. 2020 Jan 27;64(2): - PubMed
  9. Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1895-1900 - PubMed
  10. Bioengineering (Basel). 2018 Jun 14;5(2): - PubMed
  11. APMIS Suppl. 2013 May;(136):1-51 - PubMed
  12. Antimicrob Agents Chemother. 2017 Jan 24;61(2): - PubMed
  13. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:2-6 - PubMed
  14. Peptides. 2006 Jun;27(6):1210-6 - PubMed
  15. BMC Microbiol. 2020 Jul 9;20(1):204 - PubMed
  16. FEMS Immunol Med Microbiol. 2010 Aug;59(3):439-46 - PubMed
  17. Foot Ankle Int. 2015 Sep;36(9):1017-24 - PubMed
  18. Pathog Dis. 2013 Jun;68(1):8-11 - PubMed
  19. PLoS One. 2008 Oct 03;3(10):e3326 - PubMed
  20. J Antimicrob Chemother. 2009 Jul;64(1):94-100 - PubMed
  21. N Engl J Med. 2017 Jun 15;376(24):2367-2375 - PubMed
  22. Int Wound J. 2017 Apr;14(2):408-413 - PubMed
  23. Wounds. 2017 Nov;29(11):346-351 - PubMed
  24. J Wound Care. 2009 Feb;18(2):54-6 - PubMed
  25. J Med Microbiol. 2016 Oct;65(10):1092-1099 - PubMed
  26. Cochrane Database Syst Rev. 2015 Mar 06;(3):CD005083 - PubMed
  27. BMC Infect Dis. 2018 Aug 2;18(1):361 - PubMed
  28. Int J Nanomedicine. 2018 Feb 16;13:991-1007 - PubMed
  29. Mediators Inflamm. 2017;2017:5217967 - PubMed
  30. Environ Microbiol. 2013 Feb;15(2):334-46 - PubMed
  31. J Med Microbiol. 2012 Aug;61(Pt 8):1062-1070 - PubMed
  32. PLoS One. 2019 Jan 31;14(1):e0211055 - PubMed
  33. J Wound Care. 2015 Jan;24(1):11-22 - PubMed
  34. J Wound Care. 2017 Mar 1;26(Sup3):S1-S154 - PubMed
  35. Curr Opin Infect Dis. 2008 Aug;21(4):385-92 - PubMed
  36. Appl Environ Microbiol. 2015 Jul;81(13):4489-97 - PubMed
  37. Antimicrob Agents Chemother. 2010 May;54(5):2112-8 - PubMed
  38. Wounds. 2017 Aug;29(8):1-9 - PubMed
  39. J Appl Microbiol. 2014 Nov;117(5):1388-99 - PubMed
  40. J Med Microbiol. 2014 Aug;63(Pt 8):1055-1065 - PubMed
  41. Ann Surg. 2019 Apr;269(4):756-766 - PubMed
  42. Int J Pediatr Otorhinolaryngol. 2012 Nov;76(11):1575-8 - PubMed
  43. Int Wound J. 2019 Apr;16(2):486-491 - PubMed
  44. J Appl Microbiol. 2008 Dec;105(6):1817-25 - PubMed
  45. Iran J Pharm Res. 2017 Spring;16(2):661-669 - PubMed
  46. Wounds. 2018 Mar;30(3):72-78 - PubMed
  47. J Funct Biomater. 2018 Jan 08;9(1): - PubMed
  48. Vasc Health Risk Manag. 2007;3(1):65-76 - PubMed
  49. Int Wound J. 2018 Oct;15(5):749-755 - PubMed
  50. Antimicrob Agents Chemother. 2009 Oct;53(10):4357-67 - PubMed
  51. PLoS One. 2012;7(1):e28737 - PubMed
  52. Int Wound J. 2013 Apr;10(2):193-9 - PubMed
  53. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6880-6889 - PubMed
  54. J Antimicrob Chemother. 2017 Jul 1;72(7):2093-2101 - PubMed
  55. Sci Rep. 2018 Apr 4;8(1):5621 - PubMed
  56. Appl Biochem Biotechnol. 2012 Jul;167(6):1778-94 - PubMed
  57. Photodiagnosis Photodyn Ther. 2014 Sep;11(3):342-50 - PubMed
  58. Pathog Dis. 2018 Jul 1;76(5): - PubMed
  59. Infect Chemother. 2018 Mar;50(1):11-20 - PubMed
  60. J Wound Care. 2018 May 2;27(5):262-271 - PubMed
  61. Wound Repair Regen. 2008 Jan-Feb;16(1):37-44 - PubMed
  62. J Antimicrob Chemother. 2016 Feb;71(2):413-21 - PubMed
  63. J Diabetes Complications. 2014 Nov-Dec;28(6):850-7 - PubMed
  64. J Med Microbiol. 2011 Mar;60(Pt 3):300-306 - PubMed
  65. J Nanobiotechnology. 2018 Jan 10;16(1):2 - PubMed
  66. PLoS Pathog. 2014 Jun 12;10(6):e1004174 - PubMed
  67. Biomed Res Int. 2016;2016:7616471 - PubMed
  68. Burns. 2019 Jun;45(4):914-922 - PubMed
  69. Biofouling. 2016;32(2):215-25 - PubMed
  70. J Wound Care. 2017 Jan 2;26(1):20-25 - PubMed
  71. Antibiotics (Basel). 2018 Oct 02;7(4): - PubMed
  72. Adv Wound Care (New Rochelle). 2015 Jul 1;4(7):373-381 - PubMed
  73. Antimicrob Agents Chemother. 2003 Jun;47(6):1979-83 - PubMed
  74. Curr Top Med Chem. 2016;16(1):99-129 - PubMed
  75. Int J Low Extrem Wounds. 2018 Mar;17(1):14-21 - PubMed
  76. Antimicrob Agents Chemother. 2012 May;56(5):2696-704 - PubMed
  77. Foods. 2018 Mar 19;7(3): - PubMed
  78. Clin Infect Dis. 2005 Jun 1;40(11):1650-6 - PubMed
  79. J Plast Reconstr Aesthet Surg. 2019 Mar;72(3):427-437 - PubMed
  80. Pathog Dis. 2019 Mar 1;77(2): - PubMed
  81. Front Microbiol. 2018 Aug 02;9:1696 - PubMed
  82. Antibiotics (Basel). 2014;3(4):509-26 - PubMed
  83. Wounds. 2017 Jun;29(6):S1-S17 - PubMed
  84. Microbiol Mol Biol Rev. 2013 Mar;77(1):1-52 - PubMed
  85. Int J Mol Sci. 2018 Apr 12;19(4): - PubMed
  86. Clin Cosmet Investig Dermatol. 2020 Nov 24;13:875-888 - PubMed
  87. Front Microbiol. 2021 Jun 04;12:701898 - PubMed
  88. J Antimicrob Chemother. 2019 Apr 1;74(4):894-906 - PubMed
  89. Int J Biol Macromol. 2016 Jul;88:361-72 - PubMed
  90. Front Microbiol. 2018 Sep 11;9:2127 - PubMed
  91. Int J Biol Macromol. 2018 Oct 15;118(Pt A):419-426 - PubMed
  92. Diabetologia. 2008 May;51(5):747-55 - PubMed
  93. Appl Environ Microbiol. 2006 Jan;72(1):956-9 - PubMed
  94. Microbiol Spectr. 2015 Jun;3(3): - PubMed
  95. J Hosp Infect. 2016 Feb;92(2):154-60 - PubMed
  96. Clin Orthop Relat Res. 2012 Oct;470(10):2663-70 - PubMed
  97. Kaohsiung J Med Sci. 2019 Nov;35(11):686-694 - PubMed
  98. Evid Based Complement Alternat Med. 2015;2015:246012 - PubMed
  99. Acta Med Croatica. 2016 Mar;70(1):33-42 - PubMed
  100. J Cell Physiol. 2019 Jun;234(6):7903-7914 - PubMed
  101. Cochrane Database Syst Rev. 2017 Jun 14;6:CD011038 - PubMed
  102. J Bacteriol. 2009 Mar;191(5):1393-403 - PubMed
  103. Phytother Res. 2012 Sep;26(9):1371-4 - PubMed
  104. Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280 - PubMed
  105. J Antimicrob Chemother. 2018 Feb 1;73(2):494-502 - PubMed
  106. Burns Trauma. 2015 Jul 22;3:9 - PubMed
  107. Open Microbiol J. 2017 Apr 28;11:53-62 - PubMed
  108. Biofouling. 2016 Nov;32(10):1259-1270 - PubMed
  109. Int J Food Microbiol. 2013 Mar 1;162(1):13-25 - PubMed
  110. Infect Immun. 2013 Feb;81(2):496-504 - PubMed
  111. Cochrane Database Syst Rev. 2018 Oct 17;10:CD010318 - PubMed
  112. Mater Sci Eng C Mater Biol Appl. 2019 May;98:503-514 - PubMed
  113. Shock. 2020 Nov;54(5):681-687 - PubMed
  114. Diabetes Metab Res Rev. 2014 Jul;30(5):350-3 - PubMed
  115. Adv Wound Care (New Rochelle). 2019 Jul 1;8(7):341-354 - PubMed
  116. Future Microbiol. 2018 May;13:711-726 - PubMed
  117. Clin Microbiol Rev. 2002 Apr;15(2):167-93 - PubMed
  118. Cochrane Database Syst Rev. 2015 Jun 24;(6):CD004123 - PubMed
  119. ACS Chem Biol. 2014 Jan 17;9(1):183-92 - PubMed
  120. PLoS One. 2011 Apr 07;6(4):e18514 - PubMed
  121. ACS Cent Sci. 2017 Mar 22;3(3):163-175 - PubMed
  122. Indian J Microbiol. 2016 Mar;56(1):1-18 - PubMed
  123. Microbiol Spectr. 2015 Jun;3(3): - PubMed
  124. Lancet Diabetes Endocrinol. 2018 Mar;6(3):186-196 - PubMed
  125. J Mater Sci Mater Med. 2018 Feb 02;29(3):22 - PubMed
  126. Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):95-107 - PubMed

Publication Types